1-3 of 3
John Robinson
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Preclinical Data with KIT D816V Inhibitor Bezuclastinib (CGT9486) Demonstrates High Selectivity and Minimal Brain Penetrance

Anna Guarnieri, Mark Chicarelli, Louann Cable, Karyn Bouhana, Francis Sullivan, Howard Ball, Jessica Sachs, Shannon Winski, John Robinson
Journal: Blood
Blood (2021) 138 (Supplement 1): 4595.
https://doi.org/10.1182/blood-2021-152770
Published: 2021
Journal Articles

ARRY-429520, a Novel KSP Inhibitor with Potent Anti-Proliferative Activity in Leukemic Cell Lines.

Christine Lemieux, Walt DeWolf, Walt Voegtli, Eli Wallace, Rich Woessner, Chris Corrette, Shelley Allen, Jeremy Hans, Qian Zhao, Tom Aicher, Joe Lyssikatos, John Robinson, Kevin Koch, James Winkler, Stefan Gross
Journal: Blood
Blood (2006) 108 (11): 4401.
https://doi.org/10.1182/blood.V108.11.4401.4401
Published: 2006
Journal Articles

ARRY-429520, a KSP Inhibitor with Efficacy in Animal Models of Solid and Liquid Tumors.

Rich Woessner, PhD, Chris Corrette, Ph.D., Shelley Allen, Ph.D., Jeremy Hans, Ph.D., Qian Zhao, Ph.D., Tom Aicher, Ph.D., Joe Lyssikatos, Ph.D., John Robinson, Ph.D., Greg Poch, Ph.D., Laura Hayter, A.S., April Cox, M.S., Patrice Lee, Ph.D., James Winkler, Ph.D., Kevin Koch, Ph.D., Eli Wallace, Ph.D.
Journal: Blood
Blood (2006) 108 (11): 4388.
https://doi.org/10.1182/blood.V108.11.4388.4388
Published: 2006